Skip to main content
. 2003 Aug;163(2):533–542. doi: 10.1016/s0002-9440(10)63681-4

Table 1.

Characteristics of Subjects Used in the Study

Subject no. Sex Age Diagnosis Smoker Neoadjuvant therapy
1 M 55 NSCLC* Former None
2 M 56 NSCLC Former Chemo
3 F 71 Carcinoid Former None
4 F 69 NSCLC Former None
5 M 66 NSCLC Former None
6 M 61 Metastasis Former None
7 F 42 NSCLC Former Chemo
8 M 73 Lymphoma Former None
9 M 63 NSCLC Former None
10 M 85 NSCLC Former None

*Non-small-cell lung cancer.

HHS Vulnerability Disclosure